Bhaktivedanta Hospital & Research Institute, instituted in 1998, is a hospital in District Thane, India. It is located at Mira Road in District Thane, near Mumbai and caters to patients in the western suburbs from Borivali to Virar and beyond.

There are 200 beds in BhaktiVedanta Hospital and Research Institute.

During the past decade, BhaktiVedanta Hospital and Research Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BhaktiVedanta Hospital and Research Institute" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Bayer" with 1 trials sponsored, "Lupin Ltd." with 1 trials sponsored and "Mylan Pharmaceuticals Private Limited" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BhaktiVedanta Hospital and Research Institute" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "BhaktiVedanta Hospital and Research Institute" are "Migraine" (2 trials), "Advanced Non-Small Cell Lung Cancer" (1 trials), "Anemia" (1 trials), "Breast Cancer" (1 trials) and "Chronic Kidney Disease Stage 3" (1 trials). Many other conditions were trialed in "BhaktiVedanta Hospital and Research Institute" in a lesser frequency.

Most popular intervention types in "BhaktiVedanta Hospital and Research Institute" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Lasmiditan" (2 trials), "Placebo" (2 trials), "5-FU" (1 trials), "Bevacizumab" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "BhaktiVedanta Hospital and Research Institute" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "BhaktiVedanta Hospital and Research Institute". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in BhaktiVedanta Hospital and Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in BhaktiVedanta Hospital and Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".